HTA Alerts - Med Tech
Subscription service with email alerts about initiated or published health technology assessments of medical devices and in-vitro diagnostic tests from 56 HTA organizations globally
This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
Ok, I agree
Close
Health technology assessment (HTA) is a multidisciplinary process that summarizes information about the medical, social, economic and ethical issues related to the use of medical technologies in a systematic, transparent, unbiased, robust manner.

The key objective of HTA is to advise policymakers and providers about the necessity of adopting and appropriateness of reimbursing procedures, devices, and IVD tests.

Most developed countries have functioning HTA framework on different levels (national, regional, hospital-based). Only in Europe, 337 and 256 Med Tech HTA reports were released in 2018 and 2019 respectively.

HTA plays an important role in the market access landscape for medical technologies. Very often, HTA is a formal part of the reimbursement process (e.g., in France or Norway), or it is not formally connected to the reimbursement process, but it significantly impacts the adoption of technologies (e.g., in England).

Market access professionals should closely monitor new initiated and published HTAs for the products under their supervision. The key challenge for effective monitoring is a large number of HTA organizations, language barrier and lack of time to do such monitoring properly.

MTRC, a market leader in European Med Tech market access, is bringing a new service to enable effective time- and cost-effective monitoring of HTA activity in Europe and globally: HTA Alerts - Med Tech.

This is a twin service with similar activity on key reimbursement news for medical devices (procedure coding, DRG and reimbursement codes, coverage decisions, clinical guidelines etc.), "Reimbursement Alerts – Med Tech".


Key features of the service
Global coverage
The service includes key HTA organizations in Europe and globally (Australia, Brazil, Canada, Malaysia, Mexico, Singapore, Thailand and USA). In total, 56 active HTA organizations from 22 countries, producing Med Tech-related HTA reports, are included
All reports are classified according to 31 Technology Groups
The service helps to focus only on technologies of interest (e.g., cardiovascular or neuromodulating devices) and avoid wasting time on not relevant reports
All types of HTA organizations are included
The service includes international (e.g., EUnetHTA), national and regional HTAs. The service includes 56 organizations
Customized alerts and unlimited number of subscribers
All reports are customized based on the client's preferences about geographical and technological coverage. Number of enrolled subscribers from one company is unlimited
Timely alerts with essential information
Alerts about initiated or published HTAs are sent to email every 2 weeks. For each report, a title, brief summary (if available) and the link are provided
Reports are developed using a manual search
We do not trust search robots to identify and classify relevant information. The search and categorization of identified reports is performed manually by MTRC analysts

Benefits to our clients
Timely access to essential information
You can be the first to know about important developments for technology within the company and with your competition
Ability to engage with HTA stakeholders
By knowing about initiated assessment, you can engage with HTA bodies in a timely manner to provide relevant information about your technology to increase chances of more unbiased assessment and positive result of HTA
Cost-effective approach
No single Med Tech company can afford such a massive screening and monitoring activity. You outsource an essential function of keeping the company up-to-date at a modest cost. We also have 30 days money back guarantee
Customized information
You only get access to HTA information for countries (e.g., EMEA only) and technologies (e.g., peripheral vascular) of relevance to your position

Contact us to learn more and to get a quote
Once we receive your email, we will provide you with the list of HTA organizations included, pricing calculator for the service and examples of reports

About MTRC
A specialized Med Tech and IVD consultancy
13 out of top-30 global Med Tech companies routinely use reimbursement services of MTRC

Coverage of 19 European markets with consulting services

>120 reimbursement projects per year

15 full-time employees, located in six European countries

Main web-sites: Med Tech, Pharma, Online school in market access